SAGNELLI, Evangelista
 Distribuzione geografica
Continente #
EU - Europa 1.886
NA - Nord America 1.586
AS - Asia 345
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 3.823
Nazione #
US - Stati Uniti d'America 1.581
IE - Irlanda 886
IT - Italia 224
GB - Regno Unito 201
UA - Ucraina 193
CN - Cina 173
DE - Germania 171
SG - Singapore 131
GR - Grecia 71
FI - Finlandia 44
SE - Svezia 40
FR - Francia 22
TR - Turchia 22
BE - Belgio 16
KR - Corea 11
CZ - Repubblica Ceca 7
CA - Canada 4
RS - Serbia 4
IN - India 3
NL - Olanda 3
BG - Bulgaria 2
DZ - Algeria 2
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.823
Città #
Dublin 886
Jacksonville 313
Chandler 238
Princeton 126
Bremen 123
Roxbury 122
Ann Arbor 96
Singapore 73
Medford 69
Caserta 63
Cambridge 61
Beijing 58
Ashburn 37
New York 33
Woodbridge 32
Wilmington 28
Des Moines 25
Mountain View 20
Washington 20
Houston 19
Nanjing 19
Brussels 16
Munich 16
Napoli 16
Jinan 15
Boardman 12
Nanchang 11
Seoul 11
Milan 8
Ariano Irpino 7
Brno 6
San Mateo 6
Shenyang 6
Zhengzhou 6
Hangzhou 5
Lanzhou 5
Los Angeles 5
Norwalk 5
Seattle 5
Alghero 4
Belgrade 4
Elora 4
Marco 4
Naples 4
Ningbo 4
Auburn Hills 3
Changsha 3
Dearborn 3
Düsseldorf 3
Frattamaggiore 3
Guangzhou 3
Helsinki 3
Kunming 3
Marano Di Napoli 3
Putignano 3
Redwood City 3
Rome 3
Tianjin 3
Torre Del Greco 3
Avellino 2
Bologna 2
Canelli 2
Capua 2
Catania 2
Elice 2
Giffoni Valle Piana 2
Groningen 2
Haikou 2
Hefei 2
Pozzuoli 2
Saint Paul 2
San Nicola la Strada 2
Shanghai 2
Sheffield 2
Taiyuan 2
Taizhou 2
Amorosi 1
Amsterdam 1
Athens 1
Auckland 1
Aversa 1
Bangkok 1
Busto Arsizio 1
Carate Brianza 1
Cardiff 1
Chaoyang 1
Clifton 1
Edinburgh 1
Fisciano 1
Forest City 1
Fuzhou 1
Gunzenhausen 1
Hebei 1
Henderson 1
Jakarta 1
Jiaxing 1
Jinhua 1
Lappeenranta 1
Leawood 1
Luzzano 1
Totale 2.746
Nome #
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 91
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 84
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 81
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 77
Recommendations for the use of Hepatitis C virus protease inhibitors for the treatment of chronic Hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. 64
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 64
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 62
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 61
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 59
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 59
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 58
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 58
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 56
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 56
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 55
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 53
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 52
Treatment of chronic HBV infection in developing countries. 50
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 50
Clinical significance of hepatitis B surface antigen mutants 49
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 48
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 48
Hepatitis delta infection in Italian patients: towards the end of the story? 47
Virological patterns of HCV patients with failure to interferon-free regimens. 47
Role of genetic polymorphisms in hepatitis C virus chronic infection 46
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 45
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 45
Correlation between the hepatic expression of human microRNA hsa-miR-125a-5p and the progression of fibrosis in patients with overt and occult HBV infection 43
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 42
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 42
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 41
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. 40
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey 39
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 39
Absence of occult HCV infection in patients experiencing an immunodepression condition 39
HBV molecular epidemiology and clinical condition of immigrants living in Italy 38
What is changed in HBV molecular epidemiology in Italy? 37
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 37
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 37
Chronic HBV infection in pregnantimmigrants: a multicenter study of the Italian Society of Infectious and TropicalDiseases. 36
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 36
Role of occult hepatitis B virus infection in chronic hepatitis C 35
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 35
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis 34
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 34
Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy 34
Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics 34
Hepatitis c virus markers in infection by hepatitis c virus:In the era of directly acting antivirals 33
Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals. 33
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 33
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment 32
Hepatitis A virus strains circulating during 1997-2015 in Campania, a SouthernItaly region with periodic outbreaks. 32
null 32
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. 31
Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease 30
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C 30
Etiological factors of chronic hepatitis in Italy: a 2014 national survey 30
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 30
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype 29
Post Heart Transplantation Lymphoproliferative Diseases (PLDs) and the diagnostic role of [18f] FDG- PET/CT 29
Absence of occult HCV infection in HIV-positive patients 29
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 29
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 29
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 28
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy 28
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 28
The association between education level and chronic liver disease of any etiology 28
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 28
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 28
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection 27
Epidemiological and etiological variations in hepatocellular carcinoma 27
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 27
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 27
Hepatitis B virus burden in developing countries 26
Interferon-Free Regimens in HBsAg/anti-HCV Patients: The Need to Control HBV Replication to Avoid HBV Reactivation. 26
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 26
null 26
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 26
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 26
Hepatitis B virus infection in immigrant populations 24
null 23
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys 23
Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium 23
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation. 22
Human hepatitis E virus circulation in Bulgaria: deep Bayesian phylogenetic analysis for viral spread control in the country 22
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients 22
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 22
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 22
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 22
How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report 21
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 21
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 21
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy 20
Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training 19
HDV infection in immigrant populations 19
Epidemiology and management of hepatitis C virus infections in immigrant populations 19
Role of occult hepatitis B virus infection in chronic hepatitis C 19
Rescue Therapy of Refractory Diffuse Large B-Cell Lymphomas BCL2 with Venetoclax: Case Report 18
Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy 17
Primary extra-nodal dlbcl of glands: Our experiences outside guidelines of treatment 17
Totale 3.676
Categoria #
all - tutte 22.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 7 14 65 11 84 49 31 16 30 3
2020/2021469 12 8 40 11 96 26 74 39 25 52 80 6
2021/2022690 7 4 1 5 200 5 56 13 21 83 34 261
2022/20231.367 135 34 21 56 190 63 0 61 765 7 17 18
2023/2024548 36 14 37 21 214 43 3 22 2 8 27 121
2024/202518 4 14 0 0 0 0 0 0 0 0 0 0
Totale 4.133